In patients with COVID-19, upon activating the IFN-type I (IFN-I)/ IFN-α/β receptor (IFNAR) pathway, IFN-α levels are increased, which ultimately may lead to viral clearance [12]. The gene discussed is IFNA17; the disease is COVID-19.